Maie St. John, MD PhD, FACS
A highly renowned surgeon, scientist and educator, Dr. Maie St. John is Professor and Chair of Department of Head and Neck Surgery. She also holds the Samuel and Della Pearlman Chair in Head and Neck Surgery and is Co-Director of the UCLA Head and Neck Cancer Program. Dr. St. John’s laboratory studies the mechanisms of tumor progression and metastasis in head and neck cancer and seeks to identify and study novel genes and pathways for future targeted therapies, while actively incorporating the results of their laboratory-based research into the development of novel therapeutics. Her extramurally-funded research portfolio includes multiple NIH grants bridging basic science with clinical research and service. Dr. St. John is an outstanding educator who has provided mentorship to numerous trainees and serves as a member of several prestigious organizations including the Executive Council of the American Head and Neck Society, Nominating Committee of the Triological Society, and the American Academy of Otolaryngology-Head & Neck Surgery. She also is a senior examiner for the American Board of Otolaryngology and a reviewer for the American Academy of Otolaryngology/Head and Neck Surgery CORE grants, and NIH/NIDCR, NCI and NIBIB study sections. She has been the recipient of multiple awards for teaching and research. Dr. St. John received her undergraduate degree from Stanford University and both MD and PhD degrees from Yale University. She completed residency and postdoctoral training at UCLA and served previously as Chief of Head and Neck Surgery at Harbor-UCLA Medical Center. Dr. St. John’s clinical expertise is in intraoperative tumor margin delineation in the resection and treatment of head and neck cancers. Her laboratory research is translational with a focus on improving therapies and outcomes for patients with head and neck cancer. Her efforts have helped in the development of strong interdepartmental research program in Head & Neck Surgery and Bioengineering. This work has led to clinical trials and patent applications and has been consistently funded by the NIH, charitable foundations, and industry.